Expert Insights: Nursing Perspectives on the Increasing Role of PARP Inhibitors for Ovarian Cancer

Release Date: 
November 18, 2020
Expiration Date: November 18, 2021

Watch the experts in this stimulating and informative conversation about patient selection for PARP inhibitor therapy, a review of clinical data, and strategies for managing common adverse events that occur with PARP inhibitor therapy for ovarian cancer.

Target Audience

The target audience for this activity is oncology nurses, nurse practitioners, and other clinicians who treat patients with ovarian cancer with PARP inhibitors.

Learning Objectives
After completing this activity, participants should be better able to:

  • Discuss patient and disease related factors that help identify patients appropriate for PARP inhibitor maintenance therapy
  • Review clinical trial data of approved and emerging PARP inhibitor therapy strategies
  • Evaluate nursing interventions and management strategies that help prevent PARP-related adverse events and encourage patient adherence to oral therapies
  • Examine patient perspectives of PARP inhibitor therapy and nursing approaches that enhanced their experience during treatment

Paula Anastasia, RN, MN, AOCN - Moderator
Gynecologic-Oncology Clinical Nurse Specialist
Department of Obstetrics and Gynecology
University of California, Los Angeles
Los Angeles, California

Chrisann Winslow, RN, BSN, MSN(R), AOCN
Clinical Nurse Specialist and Research Coordinator
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Washington University School of Medicine
St. Louis, Missouri

Method of Participation
There are no fees for participating and receiving credit for this activity. The estimated time to complete this activity is 20 minutes. In order to receive contact hours, you must complete the following prior to the activity expiration date of November 18, 2021: 1) Read the continuing nursing education disclosures and disclaimers related to this activity; 2) Complete the pre-test; 3) Watch the presentation; 4) Successfully complete the post-test with a score of 66% (2/3) or better; 5) Complete the contact information and evaluation forms. Your certificate of completion will be available to download or print upon successful completion of the post-test and submission of your contact information and evaluation.

Accreditation Statement and Joint Providership
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is provided for 0.3 contact hours under ANCC criteria.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation (ANCC) through the joint providership of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education (UNMC CON CNE) (provider) and Bio Ascend.

Disclosure Declaration/Off-label Use
All planners and faculty participating in continuing education activities provided by the University of Nebraska Medical Center, College of Nursing Continuing Nursing Education are expected to disclose to the audience any support or relationship(s) with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in their presentation. The planners and faculty have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis. 
The following speakers and planning committee members listed below have stated they have no financial relationship(s) with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporter of this activity.
• Paula Anastasia, RN, MN, AOCN
• Dru S. Dace, PhD
• Heidi Keeler, PhD, RN
• Renee Paulin, MSN, RN, CWOCN
• Chrisann Winslow, RN, BSN, MSN(R), AOCN
This activity may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications.
The opinions expressed in the educational activity do not necessarily represent the views of UNMC CON CNE or Bio Ascend.
Non-Endorsement of Products
Accredited status as a provider of continuing nursing education refers only to the University of Nebraska Medical Center College of Nursing Continuing Nursing Education continuing education activities, and does not imply UNMC or American Nurses Credentialing Center’s Commission on Accreditation endorsement of any commercial supporters.

This educational activity is supported by an educational grant from GlaxoSmithKline.

Technical Requirements
This activity is best experienced using the most current browser (or one back) of Firefox, Chrome, Safari, Internet Explorer, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers. To view graphic images and references that appear in separate "pop-up" windows, you must have JavaScript and session cookies enabled on your computer. Adobe Acrobat Reader may be required for certain activities.

Select the Continue button below to begin. You may return later if you are unable to complete the activity at this time.